Similarly, heterozygous loss-of-function mutations in BMP receptor type II (BMPR2) and in ALK1, ENG, and BMP9 have been implicated in the pathogenesis of PAH. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.